News from Abbott A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 24, 2014, 08:00 ET

Abbott Introduces New Similac® Breastfeeding Supplement with DHA, Lutein and Vitamin E

Nutrition needs are greater when breastfeeding than any other time in a woman's life, including pregnancy, yet new research reveals diet alone may...

Jul 16, 2014, 07:45 ET

Abbott Reports Second-Quarter 2014 Results

 Abbott today announced financial results for the second quarter ended June 30, 2014. - Ongoing diluted EPS was $0.54 in the second...

Jul 14, 2014, 06:30 ET

Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan

 Abbott (NYSE: ABT) announced today that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity...

Jul 10, 2014, 14:01 ET

Abbott Builds Long-Term Commitment in China

 Today's announcement of a proposed strategic alliance with Fonterra to develop dairy farms is the latest in a series of investments Abbott...

Jul 10, 2014, 14:00 ET

Abbott and Fonterra to Form Strategic Alliance for Dairy Farming in China

 Abbott (NYSE: ABT) and Fonterra Co-operative Group Ltd today announced the signing of an agreement to develop a proposed dairy farm hub in...

Jun 25, 2014, 09:00 ET

Abbott Hosts Conference Call for Second-Quarter Earnings

 Abbott (NYSE: ABT) will announce its second-quarter 2014 financial results on Wednesday, July 16, 2014, before the market opens.  The...

Jun 24, 2014, 09:00 ET

Abbott Receives CE Mark for TECNIS® Symfony Extended Range of Vision Intraocular Lens for Cataract Patients

Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the TECNIS® Symfony Extended Range of...

Jun 23, 2014, 16:02 ET

Abbott to Acquire Veropharm

 Abbott (NYSE: ABT) today announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer. Under the...

Jun 13, 2014, 10:05 ET

Abbott Declares 362nd Consecutive Quarterly Dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 22 cents per share. This marks the 362nd...

Jun 04, 2014, 09:00 ET

Abbott to Present at William Blair 34th Annual Growth Stock Conference

 Abbott (NYSE: ABT) will present at the William Blair 34th Annual Growth Stock Conference on Wednesday, June 11, 2014. Thomas C. Freyman,...

May 16, 2014, 07:39 ET

Abbott amplía su presencia en Latinoamérica y su portafolio de productos genéricos de marca con la adquisición de CFR Pharmaceuticals

Abbott (NYSE: ABT) ha anunciado hoy un acuerdo definitivo para adquirir la empresa farmacéutica latinoamericana CFR Pharmaceuticals,...

May 16, 2014, 07:30 ET

Abbott Expands Latin American Presence and Branded Generics Portfolio with Acquisition of CFR Pharmaceuticals

Abbott (NYSE: ABT) today announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling...

May 12, 2014, 08:30 ET

Promising Preliminary Data Show Abbott's Innovative Testing Platform May Identify Life-Threatening Infections Faster Than Current Methods

Abbott (NYSE: ABT) today announced initial results that suggest its innovative testing platform, known as IRIDICA (currently in development),...

May 08, 2014, 09:30 ET

Abbott Facility Receives Top International Award for Operational Excellence

 Abbott (NYSE: ABT) has been awarded the Shingo Prize, an international award for operational excellence, by the Shingo Institute at the Jon M....

May 01, 2014, 09:00 ET

Abbott to Present at Deutsche Bank 39th Annual Health Care Conference

 Abbott (NYSE: ABT) will participate in the Deutsche Bank 39th Annual Health Care Conference on Thursday, May 8, 2014. Thomas C. Freyman,...

Apr 16, 2014, 07:45 ET

Abbott Reports First-Quarter 2014 Results

 Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2014. - Ongoing diluted EPS was $0.41 in the...

Apr 14, 2014, 09:00 ET

Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes

 Abbott (NYSE: ABT) announced today that its new ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test – which can aid physicians in...

Apr 10, 2014, 08:30 ET

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

Abbott (NYSE: ABT) today announced it has completed enrollment of three clinical trials to support approvals of the company's revolutionary...

Apr 01, 2014, 09:00 ET

Abbott Hosts Conference Call for First-Quarter Earnings

Abbott (NYSE: ABT) will announce its first-quarter 2014 financial results on Wednesday, April 16, 2014, before the market opens.  The...

Mar 28, 2014, 11:58 ET

Abbott Announces FDA Approval of Its Supera® Stent to Treat People with Peripheral Artery Disease

Abbott today announced that its Supera® Peripheral Stent System has received U.S. Food and Drug Administration (FDA) approval to treat people...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge